학술논문

Exercise Stress Echocardiography in Kawasaki Disease Patients with Coronary Aneurysms
Document Type
article
Source
Pediatric Cardiology. 44(2)
Subject
Heart Disease
Cardiovascular
Clinical Research
Prevention
Atherosclerosis
Heart Disease - Coronary Heart Disease
Biomedical Imaging
4.2 Evaluation of markers and technologies
Detection
screening and diagnosis
Humans
Coronary Aneurysm
Echocardiography
Stress
Mucocutaneous Lymph Node Syndrome
Coronary Artery Disease
Myocardial Ischemia
Exercise Test
Coronary Angiography
Kawasaki
Stress echocardiography
Coronary aneurysms
Cardiorespiratory Medicine and Haematology
Cardiovascular System & Hematology
Language
Abstract
The most significant sequelae of Kawasaki disease (KD) are coronary artery aneurysms, which can lead to risk of future myocardial ischemia. Exercise stress echocardiography allows for non-invasive assessment of myocardial dysfunction. We reviewed our single center experience with exercise stress echocardiography in patients with previous history of KD with coronary aneurysms. We reviewed the records of 53 KD patients who underwent exercise stress echocardiography from 2000 to 2020. Abnormal stress echocardiograms were defined as those showing no increase in biventricular systolic function post-exercise or regional wall motion abnormalities. Computed tomography angiography and cardiac magnetic resonance imaging were reviewed for patients with abnormal stress echocardiograms. Clinical data were reviewed and correlated with stress echocardiogram results. Of the 53 patients, three (5.7%) had an abnormal exercise stress echocardiogram. All three patients were classified as AHA Risk Level 4 or 5 by coronary Z-score (internal dimension normalized for body surface area) and were confirmed to have coronary aneurysms, stenosis, or myocardial tissue perfusion defects on advanced cardiac imaging that could account for the results seen on stress echocardiogram. Exercise stress echocardiography detected signs of myocardial ischemia in a subset of high-risk patients with Kawasaki disease and coronary aneurysms and may be considered as a useful screening tool for this complex patient cohort.